SCHEMBL845599

SCHEMBL845599

CC(C)C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccc(N(C)C)cc3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
RHOC P08134 1/20 0.43
RHOA P61586 1/20 0.43
NPC1 O15118 1/20 0.43
KCNH2 Q12809 1/20 0.42
CYP2C19 P33261 2/20 0.41
ELANE P08246 1/20 0.40
LMNA P02545 2/20 0.40
PREP P48147 2/20 0.40
POLB P06746 1/20 0.40
CYP2C9 P11712 1/20 0.40
ALDH1A1 P00352 3/20 0.39
ROCK2 O75116 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845229 0.93 RHOC (0.48) RHOCRHOANPC1CYP2C19LMNA
SCHEMBL844890 0.87 KCNH2 (0.51) NPC1KCNH2CYP2C19LMNAPOLB
SCHEMBL845340 0.87 ALDH1A1 (0.43) RHOCRHOANPC1CYP2C19LMNA
SCHEMBL844961 0.86 RHOC (0.43) RHOCRHOANPC1CYP2C19LMNA
SCHEMBL845478 0.84 NPC1 (0.43) RHOCRHOANPC1KCNH2CYP2C19
SCHEMBL845461 0.81 PREP (0.44) RHOCRHOANPC1KCNH2CYP2C19
SCHEMBL845300 0.79 CYP2C9 (0.54) RHOCRHOAKCNH2CYP2C19CYP2C9
SCHEMBL845774 0.78 CYP2C19 (0.49) NPC1CYP2C19LMNAPOLBCYP2C9
SCHEMBL844934 0.78 RHOC (0.51) RHOCRHOANPC1CYP2C19PREP
SCHEMBL845488 0.77 CYP2C19 (0.48) NPC1KCNH2CYP2C19LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed